The round was led by PSG, a leading growth equity firm that specializes in partnering with software and technology-enabled services companies. The new funding includes participation from existing and new investors including Google Ventures, Addition, Samsung Next and Dynamic Loop Capital.

Nym is a leader in transforming clinical language into actionable information, which can remove inefficiencies that add billions to the cost of care. By combining cutting-edge technology with clinical expertise and a deep understanding of medical language, Nym is able to accurately decode medical charts in a way that is efficient, explainable, and compliant. The Company's innovative solution for revenue cycle management (RCM) takes provider notes within patient charts and translates them into accurate diagnostic and billing charge codes, all within a matter of seconds and with zero human intervention. Along with over 95% accuracy of improved coding, Nym's RCM solution delivers audit-ready, traceable documentation for every code it generates, ensuring total visibility into why each code was assigned. The Nym solution can be deployed and scaled based on volume and workflow needs, easing administrative burdens and allowing clinical teams to spend more time focused on patient care.